256 filings
Page 3 of 13
8-K
4zlurn02
14 Nov 22
Submission of Matters to a Vote of Security Holders
5:15pm
8-K
iaepextk1 7acbas
2 Nov 22
Matinas BioPharma Reports Third Quarter 2022 Financial Results and Highlights Recent Progress
4:05pm
8-K
qtxiz34b3h
21 Oct 22
Matinas BioPharma Announces Positive Interim Data from the Phase 2
7:00am
8-K
o38p44i dsaqdm
13 Sep 22
Regulation FD Disclosure
7:00am
8-K
vgfhxvofhqwo9eo4
11 Aug 22
Matinas BioPharma Reports Second Quarter 2022 Financial Results and Highlights Recent Progress
6:25am
8-K
qq72uwy
12 May 22
Matinas BioPharma Reports First Quarter 2022 Financial Results and Operational Highlights
6:30am
8-K
tjsoxl3ipef3ppdvodx
13 Apr 22
Regulation FD Disclosure
8:43am
8-K
wrpq5t0 hy5nj5
11 Apr 22
BioNTech and Matinas BioPharma Announce Exclusive Research Collaboration to Evaluate Novel Delivery Technology for mRNA-based Vaccines
7:00am
S-8
ievwjyxyu 10rl
1 Apr 22
Registration of securities for employees
5:25pm
8-K
bsf2rk3r
8 Mar 22
Matinas BioPharma Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights
6:30am
8-K
p5r l8vqb
25 Jan 22
Matinas BioPharma Provides Business Update and 2022 Strategic Outlook
6:30am
8-K
0wvhmeki5
16 Dec 21
Regulation FD Disclosure
6:30am
8-K
bt1wc4fv
6 Dec 21
Matinas BioPharma Appoints Thomas Hoover, M.B.A. as Chief Business Officer
6:30am